Profluent will use its AI platform to design and optimize novel enzyme therapies for BioMarin's drug pipeline under a new collaboration.
Source article: Profluent And BioMarin Pharmaceutical Inc. Partner To Design Novel Medicines Using AI
MarketScreenerHow should this claim be treated?
ace